Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
2.96
0.00 (0.00%)
At close: Aug 15, 2025, 12:52 PM

Editas Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-237.09M -153.22M -220.43M -192.5M
Depreciation & Amortization
5.81M 6.06M 6.34M 5.05M
Stock-Based Compensation
21.42M 19.8M 29.29M 43.4M
Other Working Capital
11.81M 4.94M 8.69M -22.71M
Other Non-Cash Items
-3.87M -3.23M -724K 1.66M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.45M -1.59M 8.18M -21.41M
Operating Cash Flow
-210.28M -132.18M -177.35M -163.8M
Capital Expenditures
-8.83M -4.72M -4.12M -7.98M
Cash Acquisitions
n/a n/a 18K 46.49M
Purchase of Investments
-86.22M -258.52M -315.19M -408.89M
Sales Maturities Of Investments
257.19M 259.5M 433.35M 362.4M
Other Investing Acitivies
n/a n/a n/a -46.49M
Investing Cash Flow
162.15M -3.73M 114.07M -54.47M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 32.65M
Financial Cash Flow
56.03M 118.04M 1.28M 282.11M
Net Cash Flow
7.89M -17.87M -62M 63.84M
Free Cash Flow
-219.11M -136.9M -181.47M -171.78M